Clinical Trial Update: NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial [NA]

View source ↗

Summary

This entry documents the NOTABLE trial (AI-enabled electrocardiography) led by Northwestern University in collaboration with Tempus. The trial is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Atrial Fibrillation
• Cardiovascular Diseases
• Valvular Heart Disease

Snippet

Sponsor: Northwestern University | Conditions: Atrial Fibrillation, Cardiovascular Diseases | NA | Status: NOT_YET_RECRUITING